Conference - San Francisco, CA, United States
This conference will discuss a wide range of issues in the oncology biomarker field such as novel approaches to biomarker discovery, diagnostic and therapeutic development for cancer, utilization of next-generation sequencing in the clinic, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.
Diagnostics & Therapeutic Development for Cancer
Overcoming Challenges of Clinical Translation
Circulating/Body-Fluid Biomarkers in Oncology
Proteomic Platforms
- Mass spectrometry / Maldi
- Array
Bioinformatics in Oncology Biomarkers
- Next-Generation Sequencing
- Multiplexing Platforms
- Digital Pathology Solutions
(Courtesy of Hilton San Francisco Financial District, via www.gtcbio.com)
Wed, Mar 20, 2013 - Fri, Mar 22, 2013
Hilton San Francisco Financial District
750 Kearny Street, San Francisco, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
